Narlaprevir (trade name Arlansa, codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused by genotype 1 virus in combination with other antiviral drugs. Reference standards of Narlaprevir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Narlaprevir - API Standards [catalogue_number] => PA 14 1440000 [category_ids] => ,78,70,82,76,77, [chemical_name] => [weight] => 707.97 [form] => C36H61N5O7S [cas] => 865466-24-6 [pslug] => 865466-24-6-narlaprevir-api-pa141440000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 14 1440000
CAS :
Molecular Formula : C36H61N5O7S
Molecular Weight : 707.97
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....